The Patent Finder

Mor-NuCo Enterprises, Inc.

Also on record
Records under this name other than patents Mor-NuCo Enterprises, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to Mor-NuCo Enterprises, Inc.

PatentTitleStatus Expires Confidence
US 9,891,222Methods and compositions for identification and quantification of ENOX2 transcript variants as indications of cancer presence in blood serum and other body fluids based on gold or silver nanoparticle formation
Lapsed on the fee record
Ended Feb 13, 2026 · From the USPTO record
Lapsed on the fee recordEnded Feb 13, 2026From the USPTO record
US 9,804,165Methods and compositions for targeted two-dimensional western blot analysis for early cancer detection and cancer diagnosis up to ten years in advance of clinical symptoms of malignant disease
Lapsed on the fee record
Ended Oct 31, 2025 · From the USPTO record
Lapsed on the fee recordEnded Oct 31, 2025From the USPTO record
US 9,804,166Methods for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
Lapsed on the fee record
Ended Oct 31, 2025 · From the USPTO record
Lapsed on the fee recordEnded Oct 31, 2025From the USPTO record
US 9,739,782Methods and compositions for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
Lapsed on the fee record
Ended Aug 22, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 22, 2025From the USPTO record
US 9,612,243Methods and compositions for targeted two-dimensional western blot analysis for early cancer detection and cancer diagnosis up to ten years in advance of clinical symptoms of malignant disease
Lapsed on the fee record
Ended Apr 4, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 4, 2025From the USPTO record
US 9,459,256Methods and compositions for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
Lapsed on the fee record
Ended Oct 4, 2024 · From the USPTO record
Lapsed on the fee recordEnded Oct 4, 2024From the USPTO record
US 10,712,345Methods and compositions for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
Lapsed on the fee record
Ended Jul 14, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jul 14, 2024From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited